{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:58:40Z","timestamp":1794283120087,"version":"4.9.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesenchymal stem\/stromal cells (MSCs) are increasingly used as an intravenously applied cellular therapeutic. They were found to be potent in situations such as tissue repair or severe inflammation. Still, data are lacking with regard to the biodistribution of MSCs, their cellular or molecular target structures, and the mechanisms by which MSCs reach these targets. This review discusses current hypotheses for how MSCs can reach tissue sites. Both preclinical and clinical studies using MSCs applied intravenously or intra-arterially are discussed in the context of our current understanding of how MSCs might work in physiological and pathological situations.<\/jats:p>","DOI":"10.1186\/s13287-015-0271-2","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T17:07:42Z","timestamp":1452532062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":324,"title":["Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells"],"prefix":"10.1186","volume":"7","author":[{"given":"Johannes","family":"Leibacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Henschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"271_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the micro-environment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331\u201340.","journal-title":"Transplantation"},{"key":"271_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"271_CR3","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcb.20886","volume":"98","author":"AI Caplan","year":"2006","unstructured":"Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076\u201384.","journal-title":"J Cell Biochem"},{"key":"271_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"AI Caplan","year":"2009","unstructured":"Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009;217:318\u201324.","journal-title":"J Pathol"},{"key":"271_CR5","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1073\/pnas.132252399","volume":"99","author":"EM Horwitz","year":"2002","unstructured":"Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A. 2002;99:8932\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"271_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/6529","volume":"5","author":"EM Horwitz","year":"1999","unstructured":"Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309\u201313.","journal-title":"Nat Med"},{"key":"271_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0301-472X(00)00635-4","volume":"29","author":"SM Devine","year":"2001","unstructured":"Devine SM, Bartholomew A, Mahmud N, Nelson M, Patil S, Hardy W, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol. 2001;29:244\u201355.","journal-title":"Exp Hematol"},{"key":"271_CR8","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","volume":"101","author":"SM Devine","year":"2003","unstructured":"Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003;101:2999\u20133001.","journal-title":"Blood"},{"key":"271_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000047856","volume":"169","author":"J Gao","year":"2001","unstructured":"Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169:12\u201320.","journal-title":"Cells Tissues Organs"},{"key":"271_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","volume":"108","author":"IM Barbash","year":"2003","unstructured":"Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003;108:863\u20138.","journal-title":"Circulation"},{"key":"271_CR11","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","volume":"112","author":"D Kraitchman","year":"2005","unstructured":"Kraitchman D, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 2005;112:1451\u201361.","journal-title":"Circulation"},{"key":"271_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4:206\u201316.","journal-title":"Cell Stem Cell"},{"key":"271_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","volume":"18","author":"ON Ko\u00e7","year":"2000","unstructured":"Ko\u00e7 ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307\u201316.","journal-title":"J Clin Oncol"},{"key":"271_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.nucmedbio.2011.03.008","volume":"38","author":"A Gholamrezanezhad","year":"2011","unstructured":"Gholamrezanezhad A, Mirpour S, Bagheri M, Mohamadnejad M, Alimoghaddam K, Abdolahzadeh L, et al. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis. Nucl Med Biol. 2011;38:961\u20137.","journal-title":"Nucl Med Biol"},{"key":"271_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nm1703","volume":"14","author":"R Sackstein","year":"2008","unstructured":"Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med. 2008;14:181\u20137.","journal-title":"Nat Med"},{"key":"271_CR16","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1182\/blood-2006-05-025098","volume":"108","author":"B Ruster","year":"2006","unstructured":"Ruster B, Gottig S, Ludwig RJ, Bistrian R, Muller S, Seifried E, et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006;108:3938\u201344.","journal-title":"Blood"},{"key":"271_CR17","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1073\/pnas.1018064108","volume":"108","author":"SP Thankamony","year":"2011","unstructured":"Thankamony SP, Sackstein R. Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci U S A. 2011;108:2258\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"271_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1634\/stemcells.2006-0293","volume":"25","author":"S Schenk","year":"2007","unstructured":"Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, et al. Monocyte chemotactic protein-3 is a myocardial MSC homing factor. Stem Cells. 2007;25:245\u201351.","journal-title":"Stem Cells"},{"key":"271_CR19","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3324\/haematol.10669","volume":"92","author":"M Shi","year":"2007","unstructured":"Shi M, Li J, Liao L, Chen B, Li B, Chen L, et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD\/SCID mice. Haematologica. 2007;92:897\u2013904.","journal-title":"Haematologica"},{"key":"271_CR20","doi-asserted-by":"publisher","first-page":"13100","DOI":"10.1074\/jbc.M800184200","volume":"283","author":"IA Potapova","year":"2008","unstructured":"Potapova IA, Brink PR, Cohen IS, Doronin SV. Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem. 2008;283:13100\u20137.","journal-title":"J Biol Chem"},{"key":"271_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"A Caplan","year":"2011","unstructured":"Caplan A, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11\u20135.","journal-title":"Cell Stem Cell"},{"key":"271_CR22","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1126\/science.1172687","volume":"324","author":"TS Stappenbeck","year":"2009","unstructured":"Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science. 2009;324:1666\u20139.","journal-title":"Science"},{"key":"271_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","volume":"77","author":"D Furlani","year":"2009","unstructured":"Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77:370\u20136.","journal-title":"Microvasc Res"},{"key":"271_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/9780470631119.ch8","volume-title":"Applications of flow cytometry in stem cell research and tissue regeneration","author":"S Sharma","year":"2010","unstructured":"Sharma S, Krishan A. Hematopoietic Stem Cells. In: Krishan A, Krishnamurthy H, Totey S, editors. Applications of flow cytometry in stem cell research and tissue regeneration. New Jersey: Wiley-Blackwell; 2010. p. 103\u201314."},{"key":"271_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0301-472X(98)00017-4","volume":"27","author":"JM Radley","year":"1999","unstructured":"Radley JM, Ellis S, Palatsides M, Williams B, Bertoncello I. Ultrastructure of primitive hematopoietic stem cells isolated using probes of functional status. Exp Hematol. 1999;27:365\u20139.","journal-title":"Exp Hematol"},{"key":"271_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5:54\u201363.","journal-title":"Cell Stem Cell"},{"key":"271_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/14653240903401840","volume":"12","author":"E Deak","year":"2010","unstructured":"Deak E, R\u00fcster B, Keller L, Eckert K, Fichtner I, Seifried E, et al. Suspension medium influences interaction of mesenchymal stromal cells with endothelium and pulmonary toxicity after transplantation in mice. Cytotherapy. 2010;12:260\u20134.","journal-title":"Cytotherapy"},{"issue":"5","key":"271_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683\u201392.","journal-title":"Stem Cells Dev"},{"issue":"7","key":"271_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.5966\/sctm.2012-0187","volume":"2","author":"E Kerkel\u00e4","year":"2013","unstructured":"Kerkel\u00e4 E, Hakkarainen T, M\u00e4kel\u00e4 T, Raki M, Kambur O, Kilpinen L, et al. Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue. Stem Cells Transl Med. 2013;2(7):510\u201320.","journal-title":"Stem Cells Transl Med"},{"key":"271_CR30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/STROKEAHA.107.502047","volume":"39","author":"P Walczak","year":"2008","unstructured":"Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39:1569\u201374.","journal-title":"Stroke"},{"key":"271_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jcyt.2014.12.004","volume":"17","author":"T M\u00e4kel\u00e4","year":"2015","unstructured":"M\u00e4kel\u00e4 T, Takalo R, Arvola O, Haapanen H, Yannopoulos F, Blanco R, et al. Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model. Cytotherapy. 2015;17:392\u2013402.","journal-title":"Cytotherapy"},{"key":"271_CR32","doi-asserted-by":"publisher","first-page":"e0114962","DOI":"10.1371\/journal.pone.0114962","volume":"10","author":"K Toupet","year":"2015","unstructured":"Toupet K, Maumus M, Luz-Crawford P, Lombardo E, Lopez-Belmonte J, van Lent P, et al. Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis. PLoS One. 2015;10:e0114962.","journal-title":"PLoS One"},{"key":"271_CR33","doi-asserted-by":"publisher","first-page":"F315","DOI":"10.1152\/ajprenal.00098.2008","volume":"295","author":"F T\u00f6gel","year":"2008","unstructured":"T\u00f6gel F, Yang Y, Zhang P, Hu Z, Westenfelder C. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am J Physiol Renal Physiol. 2008;295:F315\u201321.","journal-title":"Am J Physiol Renal Physiol"},{"key":"271_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000360667","volume":"126","author":"M Morigi","year":"2014","unstructured":"Morigi M, De Coppi P. Cell therapy for kidney injury: different options and mechanisms\u2014mesenchymal and amniotic fluid stem cells. Nephron Exp Nephrol. 2014;126:59.","journal-title":"Nephron Exp Nephrol"},{"issue":"3","key":"271_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/CIRCRESAHA.108.187724","volume":"104","author":"C Toma","year":"2009","unstructured":"Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ Res. 2009;104(3):398\u2013402.","journal-title":"Circ Res"},{"key":"271_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/scrt544","volume":"6","author":"LL Cui","year":"2015","unstructured":"Cui LL, Kerkel\u00e4 E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, et al. The cerebral embolism evoked by intraaterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 2015;6:11.","journal-title":"Stem Cell Res Ther"},{"key":"271_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42\u20139.","journal-title":"Nat Med"},{"key":"271_CR38","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.1103650108","volume":"108","author":"S Chiesa","year":"2011","unstructured":"Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A, et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci U S A. 2011;108:17384\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"271_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","volume":"10","author":"K Akiyama","year":"2012","unstructured":"Akiyama K, Chen C, Wang D, Xu X, Qu C, Yamaza T, et al. Mesenchymal stem cell-induced immunoregulation involves Fas ligand\/Fas-mediated T cell apoptosis. Cell Stem Cell. 2012;10(5):544\u201355.","journal-title":"Cell Stem Cell"},{"key":"271_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2010-12-327353","volume":"118","author":"H Choi","year":"2011","unstructured":"Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-\u03baB signaling in resident macrophages. Blood. 2011;118:330\u20138.","journal-title":"Blood"},{"key":"271_CR41","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","volume":"37","author":"J Kim","year":"2009","unstructured":"Kim J, Hematti P. Mesenchymal stem celleducated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009;37:1445\u201353.","journal-title":"Exp Hematol"},{"issue":"2","key":"271_CR42","doi-asserted-by":"publisher","first-page":"e9252","DOI":"10.1371\/journal.pone.0009252","volume":"5","author":"J Maggini","year":"2010","unstructured":"Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazz\u00f3n IM, Nepomnaschy I, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010;5(2):e9252.","journal-title":"PLoS One"},{"key":"271_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/mt.2011.189","volume":"20","author":"M Francois","year":"2011","unstructured":"Francois M, Romieu-Mourez R, Li M, Galipeau J. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther. 2011;20:187\u201395.","journal-title":"Mol Ther"},{"key":"271_CR44","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","volume":"180","author":"M Sasaki","year":"2008","unstructured":"Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581\u20137.","journal-title":"J Immunol"},{"key":"271_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakanos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383\u201396.","journal-title":"Nat Rev Immunol"},{"key":"271_CR46","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499\u2013506.","journal-title":"Blood"},{"key":"271_CR47","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/stem.1118","volume":"30","author":"L von Bahr","year":"2012","unstructured":"von Bahr L, Batsis I, Moll G, H\u00e4gg M, Szakos A, Sundberg B, et al. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012;30:1575\u20138.","journal-title":"Stem Cells"},{"key":"271_CR48","doi-asserted-by":"publisher","first-page":"H1370","DOI":"10.1152\/ajpheart.00523.2005","volume":"290","author":"VFM Segers","year":"2006","unstructured":"Segers VFM, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJML, et al. Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. Am J Physiol Heart Circ Physiol. 2006;290:H1370\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"271_CR49","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1091\/mbc.E07-02-0166","volume":"18","author":"JE Ip","year":"2007","unstructured":"Ip JE, Wu Y, Huang J, Zhang L, Pratt RE, Dzau VJ. Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell. 2007;18:2873\u201382.","journal-title":"Mol Biol Cell"},{"key":"271_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12015-011-9293-z","volume":"8","author":"Y Wu","year":"2012","unstructured":"Wu Y, Zhao RC. The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev. 2012;8:243\u201350.","journal-title":"Stem Cell Rev"},{"key":"271_CR51","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1096\/fj.06-6558com","volume":"21","author":"M Zhang","year":"2007","unstructured":"Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007;21:3197\u2013207.","journal-title":"FASEB J"},{"key":"271_CR52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2008.03.003","volume":"2","author":"F Belema-Bedada","year":"2008","unstructured":"Belema-Bedada F, Uchida S, Martire A, Kostin S, Braun T. Efficient homing of multipotent adult MSCs depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell. 2008;2:566\u201375.","journal-title":"Cell Stem Cell"},{"key":"271_CR53","doi-asserted-by":"publisher","first-page":"H275","DOI":"10.1152\/ajpheart.00765.2009","volume":"298","author":"Y Wang","year":"2010","unstructured":"Wang Y, Zhang D, Ashraf M, Zhao T, Huang W, Ashraf A, et al. Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol. 2010;298:H275\u201386.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"271_CR54","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3109\/14653240903067299","volume":"11","author":"JP Laurila","year":"2009","unstructured":"Laurila JP, Laatikainen L, Castellone MD, Trivedi P, Heikkila J, Hinkkanen A, et al. Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy. 2009;11:726\u201337.","journal-title":"Cytotherapy"},{"key":"271_CR55","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.micinf.2014.08.016","volume":"16","author":"Jasmin","year":"2014","unstructured":"Jasmin, Jelicks LA, Tanowitz HB, Peters VM, Mendez-Otero R, de Carvalho AC C, et al. Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease. Microbes Infect. 2014;16:923\u201335.","journal-title":"Microbes Infect"},{"key":"271_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013;2:107\u201311.","journal-title":"Stem Cells Transl Med"},{"key":"271_CR57","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012;307:1169\u201377.","journal-title":"JAMA"},{"key":"271_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev.med.59.061506.154239","volume":"59","author":"BD Humphreys","year":"2008","unstructured":"Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med. 2008;59:311\u201325.","journal-title":"Annu Rev Med"},{"key":"271_CR59","doi-asserted-by":"publisher","first-page":"e.000028.01","DOI":"10.3205\/ctt-2008-en-000028.01","volume":"1","author":"A Gooch","year":"2008","unstructured":"Gooch A, Doty J, Flores J, Swenson L, Toegel FE, Reiss GR, et al. Initial report on a phase I clinical trial: prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cells in patients who require on-pump cardiac surgery. Cell Ther Transplant. 2008;1:e.000028.01. doi:10.3205\/ctt-2008-en-000028.01.","journal-title":"Cell Ther Transplant"},{"key":"271_CR60","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1073\/pnas.0601436103","volume":"103","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto H, Mundel TM, Sund M. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A. 2006;103:7321\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"271_CR61","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","volume":"15","author":"M Morigi","year":"2004","unstructured":"Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15(7):1794\u2013804.","journal-title":"J Am Soc Nephrol"},{"key":"271_CR62","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1681\/ASN.2006121318","volume":"18","author":"B Imberti","year":"2007","unstructured":"Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol. 2007;18:2921\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"271_CR63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2008070798","volume":"20","author":"S Bruno","year":"2009","unstructured":"Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009;20:1053\u201367.","journal-title":"J Am Soc Nephrol"},{"key":"271_CR64","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.jcyt.2014.07.003","volume":"16","author":"A Briquet","year":"2014","unstructured":"Briquet A, Gr\u00e9goire C, Comblain F, Servais L, Zeddou M, Lechanteur C, et al. Human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD\/SCID\/IL-2R\u03b3(null) mice. Cytotherapy. 2014;16:1511\u20138.","journal-title":"Cytotherapy"},{"issue":"5","key":"271_CR65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/scd.2014.0243","volume":"24","author":"S Zhang","year":"2015","unstructured":"Zhang S, Lv C, Yang X, Han Z, Zhang S, Zhang J, et al. Corticosterone mediates the inhibitory effect of restraint stress on the migration of mesenchymal stem cell to carbon tetrachloride-induced fibrotic liver by downregulating CXCR4\/7 expression. Stem Cells Dev. 2015;24(5):587\u201396.","journal-title":"Stem Cells Dev"},{"issue":"4","key":"271_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062363","volume":"8","author":"Q Li","year":"2013","unstructured":"Li Q, Zhou X, Shi Y, Li J, Zheng L, Cui L, et al. In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS One. 2013;8(4), e62363.","journal-title":"PLoS One"},{"key":"271_CR67","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1053\/j.gastro.2010.10.013","volume":"140","author":"B Parekkadan","year":"2011","unstructured":"Parekkadan B, Upadhyay R, Dunham J, Iwamoto Y, Mizoguchi E, Mizoguchi A, et al. Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b\u2009+\u2009splenocytes. Gastroenterology. 2011;140:966\u201375.","journal-title":"Gastroenterology"},{"key":"271_CR68","doi-asserted-by":"crossref","unstructured":"Wu M, Ji S, Xiao S, Kong Z, Fang H, Zhang Y, et al. JAM-A promotes wound healing by enhancing both homing and secretion activities of mesenchymal stem cells. Clin Sci (Lond). 2015. [Epub ahead of print].","DOI":"10.1042\/CS20140735"},{"key":"271_CR69","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"S Kidd","year":"2009","unstructured":"Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 2009;27:2614.","journal-title":"Stem Cells"},{"key":"271_CR70","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1634\/stemcells.22-5-812","volume":"22","author":"C Fathke","year":"2004","unstructured":"Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004;22:812.","journal-title":"Stem Cells"},{"key":"271_CR71","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","volume":"25","author":"Y Wu","year":"2007","unstructured":"Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25:2648.","journal-title":"Stem Cells"},{"key":"271_CR72","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3727\/000000007783472435","volume":"16","author":"J Wu","year":"2008","unstructured":"Wu J, Sun Z, Sun H-S, Wu J, Weisel RD, Keating A, et al. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant. 2008;16:993\u20131005.","journal-title":"Cell Transplant"},{"key":"271_CR73","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/STROKEAHA.110.597088","volume":"42","author":"G Yilmaz","year":"2011","unstructured":"Yilmaz G, Vital S, Yilmaz CE, Stokes KY, Alexander JS, Granger DN. Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature. Stroke. 2011;42:806\u201311.","journal-title":"Stroke"},{"key":"271_CR74","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.nbd.2012.03.002","volume":"46","author":"L Wei","year":"2012","unstructured":"Wei L, Fraser JL, Lu ZY, Hu X, Yu SP. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis. 2012;46:635\u201345.","journal-title":"Neurobiol Dis"},{"key":"271_CR75","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/stem.194","volume":"27","author":"G Constantin","year":"2009","unstructured":"Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells. 2009;27:2624\u201335.","journal-title":"Stem Cells"},{"key":"271_CR76","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/328429a0","volume":"328","author":"PJ Simmons","year":"1987","unstructured":"Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature. 1987;328:429\u201332.","journal-title":"Nature"},{"key":"271_CR77","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood.V96.10.3637","volume":"96","author":"D Cilloni","year":"2000","unstructured":"Cilloni D, Carlo-Stella C, Falzetti F, Sammarelli G, Regazzi E, Colla S, et al. Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood. 2000;96:3637\u201343.","journal-title":"Blood"},{"key":"271_CR78","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.exphem.2005.02.004","volume":"33","author":"K Rieger","year":"2005","unstructured":"Rieger K, Marinets O, Fietz T, K\u00f6rper S, Sommer D, M\u00fccke C, et al. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation. Exp Hematol. 2005;33:605\u201311.","journal-title":"Exp Hematol"},{"key":"271_CR79","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/sj.leu.2402763","volume":"17","author":"WJ Rombouts","year":"2003","unstructured":"Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003;17:160\u201370.","journal-title":"Leukemia"},{"key":"271_CR80","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1182\/blood-2011-07-367680","volume":"119","author":"A Follenzi","year":"2012","unstructured":"Follenzi A, Raut S, Merlin S, Sarkar R, Gupta S. Role of bone marrow transplantation for correcting hemophilia A in mice. Blood. 2012;119:5532\u201342.","journal-title":"Blood"},{"key":"271_CR81","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1182\/blood-2011-12-400085","volume":"120","author":"S Otsuru","year":"2012","unstructured":"Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood. 2012;120:1933\u201341.","journal-title":"Blood"},{"key":"271_CR82","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/cdd.2009.187","volume":"17","author":"A S\u00e9mont","year":"2010","unstructured":"S\u00e9mont A, Mouiseddine M, Fran\u00e7ois A, Demarquay C, Mathieu N, Chapel A, et al. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ. 2010;17:952\u201361.","journal-title":"Cell Death Differ"},{"key":"271_CR83","doi-asserted-by":"publisher","first-page":"261750","DOI":"10.1155\/2012\/261750","volume":"2012","author":"E Fakhrejahani","year":"2012","unstructured":"Fakhrejahani E, Toi M. Tumor angiogenesis: pericytes and maturation are not to be ignored. J Oncol. 2012;2012:261750.","journal-title":"J Oncol"},{"key":"271_CR84","first-page":"209","volume":"130","author":"N D\u2019souza","year":"2013","unstructured":"D\u2019souza N, Burns JS, Grisendi G, Candini O, Veronesi E, Piccinno S, et al. MSC and tumors: homing, differentiation, and secretion influence therapeutic potential. Adv Biochem Eng Biotechnol. 2013;130:209\u201366.","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"271_CR85","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.bjc.6604508","volume":"99","author":"BM Beckermann","year":"2008","unstructured":"Beckermann BM, Kallifatidis G, Groth A, Frommhold D, Apel A, Mattern J, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer. 2008;99:622\u201331.","journal-title":"Br J Cancer"},{"key":"271_CR86","doi-asserted-by":"publisher","first-page":"e35148","DOI":"10.1371\/journal.pone.0035148","volume":"7","author":"M Alieva","year":"2012","unstructured":"Alieva M, Bag\u00f3 JR, Aguilar E, Soler-Botija C, Vila OF, Molet J, et al. Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response. PLoS One. 2012;7:e35148.","journal-title":"PLoS One"},{"key":"271_CR87","doi-asserted-by":"crossref","unstructured":"Knoop K, Schwenk N, Schmohl K, M\u00fcller A, Zach C, Cyran C, et al. Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene. J Nucl Med. 2015;pii:jnumed.114.146662.","DOI":"10.2967\/jnumed.114.146662"},{"key":"271_CR88","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/stem.787","volume":"30","author":"S Xu","year":"2012","unstructured":"Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo. Stem Cells. 2012;30:266\u201379.","journal-title":"Stem Cells"},{"key":"271_CR89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/cncr.24013","volume":"115","author":"X Duan","year":"2009","unstructured":"Duan X, Guan H, Cao Y, Kleinerman ES. Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. Cancer. 2009;115:13\u201322.","journal-title":"Cancer"},{"key":"271_CR90","doi-asserted-by":"publisher","first-page":"e30563","DOI":"10.1371\/journal.pone.0030563","volume":"7","author":"S Kidd","year":"2012","unstructured":"Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One. 2012;7:e30563.","journal-title":"PLoS One"},{"key":"271_CR91","first-page":"787","volume":"1","author":"G Grisendi","year":"2011","unstructured":"Grisendi G, Bussolari R, Veronesi E, Piccinno S, Burns JS, De Santis G, et al. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res. 2011;1:787\u2013805.","journal-title":"Am J Cancer Res"},{"key":"271_CR92","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2119\/molmed.2010.00157","volume":"17","author":"K Suzuki","year":"2011","unstructured":"Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med. 2011;17:579\u201387.","journal-title":"Mol Med"},{"key":"271_CR93","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijms15034142","volume":"15","author":"B Yu","year":"2014","unstructured":"Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014;15:4142\u201357.","journal-title":"Int J Mol Sci"},{"key":"271_CR94","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12015-014-9545-9","volume":"11","author":"C Akyurekli","year":"2015","unstructured":"Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev. 2015;11:150\u201360.","journal-title":"Stem Cell Rev"},{"key":"271_CR95","first-page":"1","volume":"16","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 2015;16:1\u201312.","journal-title":"J Neurosurg"},{"key":"271_CR96","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/stem.1409","volume":"31","author":"H Xin","year":"2013","unstructured":"Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31:2737\u201346.","journal-title":"Stem Cells"},{"key":"271_CR97","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/scd.2012.0266","volume":"22","author":"S Tomasoni","year":"2013","unstructured":"Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev. 2013;22:772\u201380.","journal-title":"Stem Cells Dev"},{"key":"271_CR98","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","volume":"28","author":"L Kordelas","year":"2014","unstructured":"Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28:970\u20133.","journal-title":"Leukemia"},{"key":"271_CR99","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","volume":"107","author":"GM Spaggiari","year":"2006","unstructured":"Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006;107:1484\u201390.","journal-title":"Blood"},{"key":"271_CR100","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/stem.1563","volume":"32","author":"M Giuliani","year":"2014","unstructured":"Giuliani M, Bennaceur-Griscelli A, Nanbakhsk A, Oudrhiri N, Chouaib S, Azzarone B, et al. TLR ligands stimulation protects MSC from NK killing. Stem Cells. 2014;32:290\u2013300.","journal-title":"Stem Cells"},{"key":"271_CR101","doi-asserted-by":"publisher","first-page":"10000166","DOI":"10.4172\/2157-7633.1000166","volume":"4","author":"ME Reinders","year":"2014","unstructured":"Reinders ME, Hoogduijn MJ. NK cells and MSCs: possible implications for MSC therapy in renal transplantation. J Stem Cell Res Ther. 2014;4:10000166.","journal-title":"J Stem Cell Res Ther"},{"key":"271_CR102","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/stem.1111","volume":"30","author":"G Moll","year":"2012","unstructured":"Moll G, Rasmusson-Duprez I, Von Bahr L, Conolly-Andersen AM, Elgue G, Funke L, et al. Are therapeutic human mesenchymal stromal cells compatible with human blood. Stem Cells. 2012;30:1565\u201374.","journal-title":"Stem Cells"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0271-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-015-0271-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0271-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-015-0271-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T18:53:05Z","timestamp":1718304785000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-015-0271-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1186\/s13287-015-0271-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]},"assertion":[{"value":"11 January 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}